Total Brain (ASX:TTBO) 5-Year ROIIC % : 32.14% (As of Jun. 2022)


What is Total Brain 5-Year ROIIC %?

Total Brain ASX:TTBO 5-Year ROIIC % is 32.14 as of Jun. 2022. The stock has 6 warning signs investors should review.

5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year. Total Brain's 5-Year ROIIC % for the quarter that ended in Jun. 2022 was 32.14%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Total Brain's 5-Year ROIIC % or its related term are showing as below:

ASX:TTBO's 5-Year ROIIC % is not ranked
in the Healthcare Providers & Services industry.
Industry Median: 3.33 vs ASX:TTBO: 32.14

Total Brain  (ASX:TTBO) 5-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Total Brain 5-Year ROIIC % Related Terms


Total Brain 5-Year ROIIC % Historical Data

* Premium members only.

The historical data trend for Total Brain's 5-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Total Brain 5-Year ROIIC % Chart

Total Brain Annual Data
Trend Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
5-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.60 35.21 19.63 42.80 32.14

Total Brain Semi-Annual Data
Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22
5-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 42.80 0.00 32.14 0.00

ASX:TTBO vs PEARQ, BBLNF, MITI: 5-Year ROIIC % Comparison

For the Health Information Services subindustry, Total Brain's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Total Brain 5-Year ROIIC % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Total Brain's 5-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Total Brain's 5-Year ROIIC % falls into.



Total Brain 5-Year ROIIC % Calculation

Total Brain's 5-Year ROIIC % for the quarter that ended in Jun. 2022 is calculated as:

5-Year ROIIC %=5-Year Incremental Net Operating Profit After Taxes (NOPAT)**/5-Year Incremental Invested Capital**
=( -6.635 (Jun. 2022) - -2.2898442 (Jun. 2017) )/( 11.767 (Jun. 2022) - 25.286 (Jun. 2017) )
=-4.3451558/-13.519
=32.14%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.

Frequently Asked Questions Learn more about 5-Year ROIIC % →
What does a 5-Year ROIIC % of 32.14 mean?
Total Brain (ASX:TTBO) has a 5-Year ROIIC % of 32.14 as of Jun. 2022. 5-Year ROIIC % measures the change in earnings as a percentage of change in investment over 5-year. View historical data on Total Brain and its competitors.
Is Total Brain's 5-Year ROIIC % too high?
Total Brain's current 5-Year ROIIC % is 32.14. The Healthcare Providers & Services industry median 5-Year ROIIC % is 3.33. Total Brain's value of 32.14 is 865.2% above this industry median.
How does Total Brain's 5-Year ROIIC % compare to PEARQ and BBLNF?
Total Brain's 5-Year ROIIC % of 32.14 can be compared against companies in the Healthcare Providers & Services industry. The industry median 5-Year ROIIC % is 3.33. Total Brain's value of 32.14 is 865.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year ROIIC % for a Healthcare Providers & Services company?
The median 5-Year ROIIC % among Healthcare Providers & Services companies is 3.33, based on 534 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Total Brain's current 5-Year ROIIC % of 32.14 is 865.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year ROIIC % mean?
A high 5-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 5-Year ROIIC % measures the change in earnings as a percentage of change in investment over 5-year. View historical data on Total Brain and its competitors. For the Healthcare Providers & Services industry, the median 5-Year ROIIC % is 3.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Total Brain's current 5-Year ROIIC % is 32.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Total Brain stock overvalued right now?
Total Brain (ASX:TTBO) has a current 5-Year ROIIC % of 32.14. The current 5-Year ROIIC % is 32.14 and 865.2% above the Healthcare Providers & Services industry median of 3.33. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year ROIIC % calculated?
5-Year ROIIC % is calculated from a company's financial statements. For Total Brain (ASX:TTBO), the current 5-Year ROIIC % is 32.14 as of Jun. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Total Brain Business Description

Address 15 Belvoir Street, Surry Hills, NSW, AUS, 2010
Total Brain Ltd offers brain performance management platform. The company has build and validate digital tools to access, monitor, screen, and train the brain at the capacity makers level. It operates through one segment namely, development and commercialisation of brain health products.